Avoiding Audit Traps for Intravitreal Injections – Retinal Physician

Medicare pays out a lot of money for these treatments, so expect close scrutiny.

Retina specialists perform many intravitreal injections. Their frequent use means they can garner extra attention from the Centers for Medicare and Medicaid Services (CMS).

This article addresses the following questions:

  • Why is Medicare focusing on these claims?
  • What can we do to avoid audit traps?
  • Why the requirement for a 28-day interval?
  • What happens if we’re audited?
  • What can we do to avoid an audit?

This article was published in Retinal Physician, which is written by Corcoran’s Executive Vice-President, Suzanne Corcoran, COE. To view the entire article in Retinal Physician, click on the link below:


Related Posts

Website by MIC